WealthTrust Axiom’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.9K Buy
3,910
+120
+3% +$1.2K 0.01% 288
2025
Q4
$31.6K Buy
3,790
+720
+23% +$7.27K 0.01% 272
2025
Q3
$36.8K Sell
3,070
-1,680
-35% -$20.5K 0.01% 269
2025
Q2
$40.3K Buy
4,750
+800
+20% +$8.16K 0.01% 258
2025
Q1
$44.6K Buy
3,950
+50
+1% +$907 0.01% 249
2024
Q4
$79.6K Buy
3,900
+100
+3% +$2.92K 0.02% 244
2024
Q3
$151K Buy
3,800
+650
+21% +$17.5K 0.04% 245
2024
Q2
$55.4K Hold
3,150
0.02% 244
2024
Q1
$52.3K Hold
3,150
0.02% 251
2023
Q4
$59.5K Buy
3,150
+1,040
+49% +$19.5K 0.02% 241
2023
Q3
$43.9K Buy
+2,110
New +$64.1K 0.02% 233
2016
Q4
Sell
-119
Closed -$87K 233
2016
Q3
$87K Sell
119
-2
-2% -$1.62K 0.03% 212
2016
Q2
$100K Buy
+121
New +$113K 0.04% 210

Other funds holding RMTI

WealthTrust Axiom's RMTI Position: Q1 2026 in Review

WealthTrust Axiom increased its Rockwell Medical (RMTI) stake by 3.2% in Q1 2026, buying an estimated $1.2K and bringing the position to 3,910 shares worth $34.9K. The position accounts for 0.01% of the portfolio, ranked #288.

WealthTrust Axiom first reported a position in RMTI in Q2 2016 and has held it in 13 quarters since. The position peaked at $151K in Q3 2024. 42 funds tracked by Wall St. Rank hold RMTI as of Q1 2026.

  • WealthTrust Axiom held 3,910 shares of Rockwell Medical worth $34.9K as of Q1 2026.
  • WealthTrust Axiom bought 120 Rockwell Medical shares in Q1 2026, an estimated $1.2K.
  • Rockwell Medical made up 0.01% of WealthTrust Axiom's portfolio in Q1 2026, its #288 holding.
  • WealthTrust Axiom first reported a position in Rockwell Medical in Q2 2016 and has held it in 13 quarters since.
  • WealthTrust Axiom's Rockwell Medical position peaked at $151K in Q3 2024.
  • 42 funds tracked by Wall St. Rank held Rockwell Medical as of Q1 2026.

Based on WealthTrust Axiom's 13F filing for Q1 2026, filed 11 May 2026.